3rd Circ. Won't Cut McKesson's Debt To Obesity Drug Co.
The Third Circuit on Friday refused to erase McKesson Corp.'s $7 million obligation to former obesity drugmaker Orexigen Therapeutics Inc., ruling in a precedential decision that bankruptcy law precluded the use...To view the full article, register now.
Already a subscriber? Click here to view full article